Our PARTNERS
2 Aphena
4 West
6 Sio2
12 Pii
AMT PRODUCTS
AMT 4-in-1 Injector System Platform
PRESENTATION DECK 4-in-1 PDF
AMT Intradermal Injector System
PRESENTATION DECK INTRADERMAL PDF
Executive Team
Our founders, with first-hand field knowledge and experience, know that lives could have been saved with this technology – and will be.
Frank X. Osborne
Co-Founder and Chief Executive Officer
Mr. Osborne is an entrepreneur with over 20 years of pharmaceutical and medical device experience, and is the driving force behind AMT.
Read More
Dr. Robert Mabry
Chief Medical Advisor
Doctor Mabry most recently served as the U.S. D.O.D. Principal Deputy Assistant Secretary of Defense for Health Affairs, the principal staff assistant and advisor to the Assistant Secretary of Defense for Health Affairs (ASD HA) for clinical policies and programs.
Read More
Dr. Robert Mabry
Chief Medical Advisor
Doctor Mabry most recently served as the U.S. D.O.D. Principal Deputy Assistant Secretary of Defense for Health Affairs, the principal staff assistant, and advisor to the Assistant Secretary of Defense for Health Affairs (ASD HA) for clinical policies and programs.
Read More
Lt. Col. (RET) Andrew Contreras, DPT
Senior Vice President - Military
As an AMT Co-Founder and co-inventor of key AMT technology, Lt. Col. (RET) U.S. Army, Dr. Andrew Contreras has unique emergency medical experience, as was required when serving with the U.S. Army’s 82nd Airborne.
Read More
BARBARA Holcomb
EXECUTIVE ADVISOR
Barbara Holcomb is a retired Army Major General, having served 33 years as a leader in Nursing, Healthcare, Medical Research, and Logistics.
Read More
BARBARA Holcomb
EXECUTIVE ADVISOR
Barbara Holcomb is a retired Army Major General, having served 33 years as a leader in Nursing, Healthcare, Medical Research, and Logistics.
Read More
Doug Bryce
EXECUTIVE ADVISOR
Doug Bryce served with the U.S. Marine Corps in uniform (20 Years) and as a USMC civilian (18 years) for a total of 38 years and in the U. S. Army Senior Executive Service for (10 years).
Read More
Richard Weddle
Chief Operating Officer
Mr. Weddle has over 30 years of government and private sector experience. He is responsible for technology development, intellectual property protection, drug, and device design and development, as well as production, and also works on oversight of regulatory approval and partnership processes.
Read More
Richard Weddle
Chief Operating Officer
Mr. Weddle has over 30 years of government and private sector experience. He is responsible for technology development, intellectual property protection, drug, and device design and development, as well as production, and also works on oversight of regulatory approval and partnership processes.
Read More
BARBARA HORTON
CHIEF FINANCIAL OFFICER
Ms. Horton has over 25 years of deep financial experience across multiple industries.
Read More
Mark Pursel
Vice President - Manufacturing
Mr. Pursel is an injection molding and material thermodynamics expert, as well as a designer of automation systems, and is co-inventor of key AMT technologies.
Read More
Mark Pursel
Vice President - Manufacturing
Mr. Pursel is an injection molding and material thermodynamics expert, as well as a designer of automation systems, and is co-inventor of key AMT technologies.
Read More
Advisory Board
Lori A. Hoffman
Ms. Hoffman is an Advisor to AMT and is the Senior Director of Alliance Management for Frontida BioPharm, Inc., a contract development and manufacturing organization (CDMO).
Read More
Lori A. Hoffman
Ms. Hoffman is an Advisor to AMT and is the Senior Director of Alliance Management for Frontida BioPharm, Inc., a contract development and manufacturing organization (CDMO).
Read More
Janet Dillione
Ms. Dillione is an Advisor to AMT and is Director and member of the Board of Directors at CorMedix Inc.. a biopharmaceutical company delivering treatments for infection and inflammatory diseases.
Read More
Timothy S. Callahan
Mr. Callahan is an advisor to AMT and is an accomplished life-sciences operating executive and board member with over 25 years of experience in the biopharma industry, most recently with Actavis plc (now Allergan).
Read More
Timothy S. Callahan
Mr. Callahan is an advisor to AMT and is an accomplished life-sciences operating executive and board member with over 25 years of experience in the biopharma industry, most recently with Actavis plc (now Allergan).
Read More
Thani Jambulingam, PhD
Dr. Jambulingam is an Advisor to AMT and a professor in the Department of Pharmaceutical and Healthcare Marketing at the Erivan K. Haub School of Business, Saint Joseph’s University.
Read More
Dr. Peter G. Goldschmidt, MD, DrPH, DMS
Dr. Goldschmidt is an advisor to AMT with over 40 years of experience. Dr. Goldschmidt is president of the World Development Group, a healthcare company specializing in healthcare quality assurance, patient safety, informatics, modeling and forecasting with emphasis on medical-device development.
Read More
Dr. Peter G. Goldschmidt, MD, DrPH, DMS
Dr. Goldschmidt is an advisor to AMT with over 40 years of experience. Dr. Goldschmidt is president of the World Development Group, a healthcare company specializing in healthcare quality assurance, patient safety, informatics, modeling and forecasting with emphasis on medical-device development.
Read More
Richard Jaffe
Mr. Jaffe is a legal and strategic advisor to AMT. Mr. Jaffe has over 30 years experience and specializes in corporate law, private equity, mergers and acquisitions, corporate governance, and venture capital.
Read More